drugset / Trial / NCT05570409
Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy
Phase 2/3
Terminated
9 enrolled
LMU Klinikum
Charite University, Berlin, Germany · collabDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) · collabTechnical University of Munich · collabUniversity Hospital Erlangen · collabUniversity Hospital Tuebingen · collabUniversity Hospital, Essen · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Evaluating Immunosuppressive treatment (Mycophenolate mofetil and prednisolon compared to placebo) for 6 months in patients with chronic virus- Negative Inflammatory cardiomyopathy - a multicenter, randomized, double-blind, placebo-controlled trial.
Timeline
- Start
- 2023-03-28
- Primary completion
- 2025-04-14
- Completion
- 2025-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycophenolate Mofetil | Small molecule | 1 g | — |
| Subject | Prednisolone | Other / unclassified | 1 mg/kg | — |